Back

An online international survey study into the incidence and potential reasons of therapy non-adherence in catecholaminergic polymorphic ventricular tachycardia: preliminary results

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Ion channel diseases: risk stratification and treatment Ion Channel Disorders ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Mrs Puck Peltenburg

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

7 More presentations in this session

Presentation thumbnail
Roles of atrial arrhythmias in triggering torsade de pointes in patients with acquired long QT syndrome
Doctor R. Tochibora (Gifu, JP)
Abstract Slides Video
Presentation thumbnail
Prevalence and prognostic value of epilepsy and Brugada syndrome
Miss E. Rossetto (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Monitoring the electrophysiological effects of hydroquinidine non-invasively in patients with Brugada syndrome
Doctor J. Isbister (Sydney, AU)
Abstract Slides Video
Presentation thumbnail
Characterization of the cardiac and non-cardiac phenotype associated with genetic variants in KCNJ2
Doctor D. Abrams (Boston, US)
Abstract Slides Video
Presentation thumbnail
Interpretable machine learning model using Extreme Gradient Boosting with Nonnegative Matrix Factorization improves the accuracy of arrhythmic risk prediction in Brugada Syndrome
Professor G. Tse (Hong Kong, CN)
Abstract Slides

Access the full session

Session thumbnail
Ion channel diseases: risk stratification and treatment

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
When to consider device therapy in HFrEF - discussion
thumbnail
Congress Session
Ventricular storm (2)
thumbnail
Congress Presentation
Genetic approaches to restore cardiac conduction and prevent ventricular arrhythmias

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources